CHU Haut-Leveque Pessac 33604 France Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
1995
NCT00480064
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1995

Timeline

NOW
  • Now